Zydus Lifesciences Limited (NSE:ZYDUSLIFE)
India · Delayed Price · Currency is INR 935.00
-8.95 (-0.95%)
Apr 20, 2026, 3:29 PM IST
Zydus Lifesciences Market Cap
Zydus Lifesciences has a market cap or net worth of 949.83 billion as of April 20, 2026. Its market cap has increased by 4.03% in one year.
Market Cap
949.83B
Enterprise Value
1.00T
Revenue
260.89B
Ranking
n/a
PE Ratio
19.24
Stock Price
935.00
Market Cap Chart
Since May 15, 2002, Zydus Lifesciences's market cap has increased from 8.20B to 949.83B, an increase of 11,489.30%. That is a compound annual growth rate of 21.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 949.83B | 3.24% |
| Dec 31, 2025 | 920.05B | -5.90% |
| Dec 31, 2024 | 977.76B | 40.16% |
| Dec 29, 2023 | 697.61B | 64.11% |
| Dec 30, 2022 | 425.08B | -14.06% |
| Dec 31, 2021 | 494.62B | 1.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 1.65T |
| Cipla | 1.00T |
| Mankind Pharma | 877.26B |
| Aurobindo Pharma | 804.99B |
| Alkem Laboratories | 667.41B |
| Glenmark Pharmaceuticals | 634.81B |
| Laurus Labs | 613.14B |
| Ipca Laboratories | 372.51B |